Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-TT co-administered with Infanrix hexa in toddlers
2006-006680-23Phase 3Completed
- Sponsor
- GSK
- Start
- May 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in meningococcal disease comparing MenACWY-TT + Infanrix hexa with Infanrix hexa alone (2 arms). Started May 2007; status: completed.
02
Drugs
meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccinepertussis filamentous haemagglutinin
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2006-006680-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006680-23.